We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

40 hedge funds and large institutions have $35.8M invested in Alimera Sciences in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

2% less funds holding

Funds holding: 4140 (-1)

17% less capital invested

Capital invested by funds: $42.9M → $35.8M (-$7.14M)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

88% less call options, than puts

Call options by funds: $1K | Put options by funds: $8K

Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
11
Reduced
7
Closed
5
Calls
$1K
Puts
$8K
Net Calls
-$7K
Net Calls Change
-$74K

ALIM Hedge Fund Activity: Q1 2018 in Review

40 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2018, worth a combined $35.8M — down 17% from $42.9M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ALIM and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 11 added.

The largest buyer was Stonepine Capital Management, adding an estimated $3.1M. The largest seller was JW Asset Management, cutting an estimated $319K.

  • 40 institutional investors held Alimera Sciences (ALIM) as of Q1 2018, down from 41 in Q4 2017.
  • Funds reported $35.8M of Alimera Sciences stock for Q1 2018, down 17% quarter-over-quarter.
  • 4 funds opened new Alimera Sciences positions in Q1 2018 and 5 closed out, a net change of -1 holder.
  • The largest Alimera Sciences buyer in Q1 2018 was Stonepine Capital Management, an estimated $3.1M added.
  • The largest Alimera Sciences seller in Q1 2018 was JW Asset Management, an estimated $319K sold.

Based on aggregated 13F filings for Q1 2018.